NR4A1 and metabolic syndrome: High pretreatment triglyceride and total cholesterol levels may be related to the BC hormone receptor type (Kim et al., 2009), and post‐chemotherapy dyslipidemia may be related to CIA induced drastic hormone fluctuations (Delgobo et al., 2019; Tian et al., 2019).